Written Question·Department of Health and Social Care·UIN 116001

Rare Cancers: Medical Treatments

Tabled: 25 February 2026

Answered: 4 March 2026

Question

Clive Jones

To ask the Secretary of State for Health and Social Care, whether specialist multidisciplinary teams and designated centres of excellence will be given clear guidance and authority to prescribe off-label treatments supported by genomic evidence and aligne

Answer

Dr Zubir Ahmed

The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) are working to deliver the Government’s ambitions, as set out in the 10-Year Health Plan for England and the Life Sciences Sect...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 116001) →